Evotec AG (NASDAQ:EVTCY) | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Evotec AG

BRIEF

published on 11/14/2024 at 22:56, 6 days 11 hours ago

Evotec SE Responds to Interest from Halozyme

Evotec SE Takeover Halozyme Therapeutics Expression Of Interest EUR 11 Per Share
PRESS RELEASE

published on 11/14/2024 at 22:51, 6 days 11 hours ago

EQS-Adhoc: Comment on media report
Evotec SE receives non-binding expression of interest from Halozyme Therapeutics Inc. for a takeover offer of EUR 11.00 per share

Evotec SE Takeover Offer Expression Of Interest Halozyme Therapeutics Inc. EUR 11.00 Per Share
BRIEF

published on 11/06/2024 at 07:05, 15 days 3 hours ago

Evotec SE Reports Strategic Progress and Revenue Growth Amid Challenges

Strategic Partnerships 2024 Forecasts Biologics Growth Evotec Financial Results Priority Reset Initiative
PRESS RELEASE

published on 11/06/2024 at 07:00, 15 days 3 hours ago

Evotec SE reports 9M 2024 results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions
Evotec SE reports 9M 2024 results with strategic progress amid challenging market conditions. New partnerships and operational milestones achieved

Financial Results Evotec SE Partnerships 9M 2024 Operational Milestones
BRIEF

published on 11/05/2024 at 07:34, 16 days 3 hours ago

Evotec Divests API Manufacturing Facility to Monacum Partners

Evotec Strategic Divestment Monacum Partners API Manufacturing Priority Reset
PRESS RELEASE

published on 11/05/2024 at 07:29, 16 days 3 hours ago

Evotec Announces Sale of API Manufacturing Facility to Monacum Partners
Evotec announces sale of chemical API manufacturing facility to Monacum Partners as part of strategic optimization efforts to focus on key growth areas. Evotec DS in Halle/Westphalia to become DAPIN GmbH under new ownership

Sale Strategic Optimization Evotec Monacum Partners API Manufacturing
BRIEF

published on 10/30/2024 at 08:15, 22 days 2 hours ago

Evotec SE to Release Nine-Month 2024 Financial Results

Financial Results Conference Call Evotec SE Strategic Review Therapeutics Development
PRESS RELEASE

published on 10/30/2024 at 08:10, 22 days 2 hours ago

Evotec SE to announce results for the first nine months 2024 on 06 November 2024
Evotec SE to announce financial results for the first nine months of 2024 on 06 November 2024, including conference call discussing strategic review process

Financial Results Conference Call Evotec SE Life Science Strategic Review
BRIEF

published on 10/23/2024 at 07:34, 29 days 3 hours ago

Evotec and Bristol Myers Squibb Strengthen Proteomics Collaboration

Drug Discovery Bristol Myers Squibb Molecular Glue Degraders Proteomics Partnership Evotec Collaboration
PRESS RELEASE

published on 10/23/2024 at 07:29, 29 days 3 hours ago

Evotec and Bristol Myers Squibb expand proteomics partnership
Evotec SE and Bristol Myers Squibb expand proteomics partnership, advancing molecular glue degraders beyond oncology. Evotec receives US$50m payment

Evotec SE Oncology Bristol Myers Squibb Molecular Glue Degraders Proteomics Partnership

Accesswire

Published on 11/21/2024 at 10:03, 46 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 49 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 49 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 14 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 24 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 19 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 44 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 47 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 49 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 49 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 51 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 29 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 4 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 4 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE